Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology
Canadian Diabetes & Endocrinology Today · 25.05.2026 · 17-24
DOI: 10.58931/cdet.2026.4151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Diabetes & Endocrinology Today, online erschienen am 25.05.2026. Verfasst von Adam Millar. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In this review, “Anabolic Androgenic Steroids,” or “AAS” is used as the preferred term to indicate the use of exogenous androgens in supraphysiologic doses for the purpose of muscle growth or image enhancement. This definition does not include the use of physiologic doses of testosterone prescribed for the treatment of male hypogonadism. Although there is disagreement regarding the accuracy of this terminology, AAS continues to be one of the most common designations used in the literature today.
Zitieren
APA
Millar, A. (2026). Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology. Canadian Diabetes & Endocrinology Today, 17-24. https://doi.org/10.58931/cdet.2026.4151
Vancouver
Millar A. Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology. Canadian Diabetes & Endocrinology Today. 2026:17-24. doi:10.58931/cdet.2026.4151
BibTeX
@article{Millar2026,
author = {Millar, Adam},
title = {Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology},
journal = {Canadian Diabetes & Endocrinology Today},
year = {2026},
pages = {17--24},
doi = {10.58931/cdet.2026.4151}
}
EUVIMED